Clinical Trial Update: Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 trial evaluating preoperative percutaneous radiofrequency ablation of primary and metastatic lung tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lung Metastasis

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Lung Cancer, Lung Metastasis | Phase 2 | Status: COMPLETED